Cargando…

Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland

Charcot–Marie–Tooth disease (CMT) is the most common inherited neuropathy with heterogeneous clinical presentation and genetic background. The axonal form (CMT2) is characterised by decreased action potentials indicating primary axonal damage. The underlying pathology involves axonal degeneration wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansagi, Boglarka, Antoniadi, Thalia, Burton-Jones, Sarah, Murphy, Sinead M., McHugh, John, Alexander, Michael, Wells, Richard, Davies, Joanna, Hilton-Jones, David, Lochmüller, Hanns, Chinnery, Patrick, Horvath, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539360/
https://www.ncbi.nlm.nih.gov/pubmed/26032230
http://dx.doi.org/10.1007/s00415-015-7778-4
_version_ 1782386096142811136
author Bansagi, Boglarka
Antoniadi, Thalia
Burton-Jones, Sarah
Murphy, Sinead M.
McHugh, John
Alexander, Michael
Wells, Richard
Davies, Joanna
Hilton-Jones, David
Lochmüller, Hanns
Chinnery, Patrick
Horvath, Rita
author_facet Bansagi, Boglarka
Antoniadi, Thalia
Burton-Jones, Sarah
Murphy, Sinead M.
McHugh, John
Alexander, Michael
Wells, Richard
Davies, Joanna
Hilton-Jones, David
Lochmüller, Hanns
Chinnery, Patrick
Horvath, Rita
author_sort Bansagi, Boglarka
collection PubMed
description Charcot–Marie–Tooth disease (CMT) is the most common inherited neuropathy with heterogeneous clinical presentation and genetic background. The axonal form (CMT2) is characterised by decreased action potentials indicating primary axonal damage. The underlying pathology involves axonal degeneration which is supposed to be related to axonal protein dysfunction caused by various gene mutations. The overlapping clinical manifestation of CMT2 with distal hereditary motor neuropathy (dHMN) and intermediate CMT causes further diagnostic difficulties. Aminoacyl-tRNA synthetases have been implicated in the pathomechanism of CMT2. They have an essential role in protein translation by attaching amino acids to their cognate tRNAs. To date six families have been reported worldwide with dominant missense alanyl-tRNA synthetase (AARS) mutations leading to clinically heterogeneous axonal neuropathies. The pathomechanism of some variants could be explained by impaired amino acylation activity while other variants implicating an editing defect need to be further investigated. Here, we report a cohort of six additional families originating from the United Kingdom and Ireland with dominant AARS-related neuropathies. The phenotypic manifestation was distal lower limb predominant sensorimotor neuropathy but upper limb impairment with split hand deformity occasionally associated. Nerve conduction studies revealed significant demyelination accompanying the axonal lesion in motor and sensory nerves. Five families have the c.986G>A, p.(Arg329His) variant, further supporting that this is a recurrent loss of function variant. The sixth family, of Irish origin, had a novel missense variant, c.2063A>G, p.(Glu688Gly). We discuss our findings and the associated phenotypic heterogeneity in these families, which expands the clinical spectrum of AARS-related neuropathies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-015-7778-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4539360
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-45393602015-08-19 Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland Bansagi, Boglarka Antoniadi, Thalia Burton-Jones, Sarah Murphy, Sinead M. McHugh, John Alexander, Michael Wells, Richard Davies, Joanna Hilton-Jones, David Lochmüller, Hanns Chinnery, Patrick Horvath, Rita J Neurol Original Communication Charcot–Marie–Tooth disease (CMT) is the most common inherited neuropathy with heterogeneous clinical presentation and genetic background. The axonal form (CMT2) is characterised by decreased action potentials indicating primary axonal damage. The underlying pathology involves axonal degeneration which is supposed to be related to axonal protein dysfunction caused by various gene mutations. The overlapping clinical manifestation of CMT2 with distal hereditary motor neuropathy (dHMN) and intermediate CMT causes further diagnostic difficulties. Aminoacyl-tRNA synthetases have been implicated in the pathomechanism of CMT2. They have an essential role in protein translation by attaching amino acids to their cognate tRNAs. To date six families have been reported worldwide with dominant missense alanyl-tRNA synthetase (AARS) mutations leading to clinically heterogeneous axonal neuropathies. The pathomechanism of some variants could be explained by impaired amino acylation activity while other variants implicating an editing defect need to be further investigated. Here, we report a cohort of six additional families originating from the United Kingdom and Ireland with dominant AARS-related neuropathies. The phenotypic manifestation was distal lower limb predominant sensorimotor neuropathy but upper limb impairment with split hand deformity occasionally associated. Nerve conduction studies revealed significant demyelination accompanying the axonal lesion in motor and sensory nerves. Five families have the c.986G>A, p.(Arg329His) variant, further supporting that this is a recurrent loss of function variant. The sixth family, of Irish origin, had a novel missense variant, c.2063A>G, p.(Glu688Gly). We discuss our findings and the associated phenotypic heterogeneity in these families, which expands the clinical spectrum of AARS-related neuropathies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00415-015-7778-4) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-06-02 2015 /pmc/articles/PMC4539360/ /pubmed/26032230 http://dx.doi.org/10.1007/s00415-015-7778-4 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Communication
Bansagi, Boglarka
Antoniadi, Thalia
Burton-Jones, Sarah
Murphy, Sinead M.
McHugh, John
Alexander, Michael
Wells, Richard
Davies, Joanna
Hilton-Jones, David
Lochmüller, Hanns
Chinnery, Patrick
Horvath, Rita
Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland
title Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland
title_full Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland
title_fullStr Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland
title_full_unstemmed Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland
title_short Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland
title_sort genotype/phenotype correlations in aars-related neuropathy in a cohort of patients from the united kingdom and ireland
topic Original Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539360/
https://www.ncbi.nlm.nih.gov/pubmed/26032230
http://dx.doi.org/10.1007/s00415-015-7778-4
work_keys_str_mv AT bansagiboglarka genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT antoniadithalia genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT burtonjonessarah genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT murphysineadm genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT mchughjohn genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT alexandermichael genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT wellsrichard genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT daviesjoanna genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT hiltonjonesdavid genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT lochmullerhanns genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT chinnerypatrick genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland
AT horvathrita genotypephenotypecorrelationsinaarsrelatedneuropathyinacohortofpatientsfromtheunitedkingdomandireland